Surveillance of multidrug-resistant bacterial isolates from bloodstream infections in Erbil, Iraq
DOI:
https://doi.org/10.3855/jidc.22460Keywords:
antibiotic-resistance, Gram-negative, multidrug-resistance, nosocomial, sepsisAbstract
Introduction: When bacteria enter the bloodstream and grow, they produce toxins that cause systemic sickness; and this leads to bloodstream infections (BSIs). BSIs are a major contributor to morbidity and mortality in hospitals. Since infections produced by multidrug-resistant (MDR) organisms are linked to greater mortality rates, the situation becomes even more complicated. This study evaluated the bacterial agents found in Erbil septicemia patients and investigated how resistant they were to antibiotics.
Methodology: Blood cultures were obtained from 81 patients at Maryamana Private Hospital who were suspected of having septicemia between March and October 2024. Automated laboratory equipment was used to identify the isolates and assess their susceptibility to antibiotics. Standard criteria were followed for classification into MDR, extensively drug-resistant (XDR), or pan-drug-resistant (PDR) categories.
Results: Around 57 (70.3%) of the 81 blood samples had bacterial growth. Around 32 (56.1%) were male and 25 (43.9%) were female. The majority were in the 30–59 years age group. More Gram-negative organisms (59.7%) than Gram-positive species (40.3%) were isolated. Staphylococcus aureus (16.1%) and Burkholderia cepacia (17.9%) were the most common bacteria. Methicillin-resistant S. aureus (MRSA) strains made for more than half of the total (55.5%). PDR was found among the Gram-negative isolates; 65.5% were MDR and 34.5% XDR.
Conclusions: The significant prevalence of resistant Gram-negative bacteria and MRSA highlights the critical need for quick diagnosis, careful antibiotic use, and improved infection control measures in healthcare environments.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Safaa Toma Hanna Aka

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

